Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 384 results for "Shionogi"

BRIEF-Shionogi & announces decision of patent revocation and p...

n"Nov 28 Shionogi & Co Ltd : * Says the co filed a counterclaim in patent court in the UK stating that Merck Sharp & Dohme Limited's "integrase inhibitor Isentress" infringes the co's UK patent on May 16, 2015 * Says on Nov. 25, patent court in ... Reuters UK, 5 days ago

17 images for Shionogi

Scrip Intelligence, 3 days ago
Scrip Intelligence, 3 days ago
Scrip Intelligence, 2 months ago
Scrip Intelligence, 2 months ago
Business Standard, 4 months ago
Business Standard India, 4 months ago
Money Control, 4 months ago
Pharma Letter, 4 months ago
International Business Times India, 4 months ago
United News of India, 4 months ago
European Pharmaceutical Review

ViiV Healthcare Launches Phase III Program to Evaluate a Long-Acting, Injectable HIV Treatment Regimen

-- ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the start of two phase III studies designed to evaluate an investigational long-acting, injectable ...
 Drugs.com5 days ago ViiV Healthcare to evaluate injectable HIV treatment  European Pharmaceutical Review1 week ago ViiV Healthcare initiates phase III programme to evaluate a long-acting, injectable HIV treatment regimen  PharmaBiz1 week ago ViiV launches phase III programme to evaluate HIV treatment  Pharma Business International1 week ago
[x]  

BRIEF-Shionogi & Co to repurchase shares at up to 35 bln yen and to retire treasury shares

n"Oct 31 Shionogi & Co Ltd : * Says it to repurchase up to 7 million shares of its common stock, representing a 2.15 percent stake * Say shares to be repurchased at the price of up to 35 billion yen in total, from Nov. 1 to Dec. 30 * Says it to ...
 Reuters UK1 month ago

Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens

OSAKA, Japan and FLORHAM PARK, N.J., Oct. 26, 2016 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") presented the results of the first global surveillance study for its in-development investigational siderophore cephalosporin, cefiderocol ...
 4 Traders1 month ago Shionogi Release: Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens  BioSpace1 month ago Secondary Endpoint Data for S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, Support Favorable Primary Endpoint Data Previously Released  4 Traders2 days ago
[x]  
Proactive Investors.co.uk

Shionogi Partnering Deals and Alliances 2010-2016 - Research and Markets

Research and Markets has announced the addition of the "Shionogi Partnering Deals and Alliances 2010 to 2016" company profile to their offering. The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering ...
 4 Traders2 weeks ago Research ad Markets - Global Allergy Immunotherapy Market Analysis & Trends - Forecast to 2025 - Key Vendors are Anergis S.A., Biomay AG & Circassia  Yahoo! Finance1 week ago Global Allergy Immunotherapy Market Analysis & Trends - Product Type & Application - Forecast to 2025 - Research and Markets  Pharmacy Choice1 week ago Resistant Pseudomonas aeruginosa Infections Therapeutics Industry Report H2 2016 - Latest News and Press Releases  Before It's News4 weeks ago
[x]  

Merck Sharp And Dohme Ltd v Shionogi & Co Ltd [2016] EWHC 2989 (Pat) (25 November 2016)

From [0099]-[0230] methods for use in the synthesis of the compounds of the invention are set out. None of this detail is material for present purposes. "[0232] The present invention is useful for preparing a pharmaceutical composition such as ...
 Bailii.org1 week ago

SHIONOGI : SASĀ® Data Management Update Extends Self-Service, Expands Access to Cloud and Big Data

Enterprises clamor to unearth more data from more sources. In response, SAS continues to beef up its data management portfolio to improve access to the best data. The expanded self-service access for business users means faster and more accurate ...
 4 Traders2 weeks ago SASĀ® Data Management update extends self-service, expands access to cloud and big data  SAS2 weeks ago
[x]  

Glaxo's ViiV starts phase III studies for HIV-1

(ShareCast News) - Specialist HIV company ViiV Healthcare, which is majority-owned by GlaxoSmithKline with Pfizer and Shionogi Limited as shareholders, has started two phase III studies to evaluate an investigational long-acting, injectable regimen ...
 Hargreaves Lansdown2 weeks ago
[x]  

Antibiotic Candidate Cefiderocol Demonstrates Activity Against Drug-Resistant Pathogens

Results from the first global surveillance study of cefiderocol (Shionogi Inc.), an investigational siderophore cephalosporin, have been presented at IDWeek 2016 in New Orleans, Louisiana. Cefiderocol showed activity against gram-negative pathogens, ...
 P&T Community1 month ago

Europe Anti Obesity Drugs Market Size, Status and Forecasts 2021

In depth analysis of Europe Anti Obesity Drugs Market is a crucial thing for various stakeholders like investors, CEOs, traders, suppliers and others. The Europe Anti Obesity Drugs Market research report is a resource, which provides technical and ...
 Before It's News1 day ago United States Anti Obesity Drugs Market Growth Forecast Analysis by Manufacturers, Regions, Type and Application to 2021  Before It's News1 week ago Global Anti Obesity Drugs Market 2016- Pfizer, Merck, Roche, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eisai  Digital Journal2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less